Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin - a novel tumor checkpoint controller targeting microtubules

Danielle M. Burgenske, Surabhi Talele, Jenny L. Pokorny, Ann C. Mladek, Katrina K. Bakken, Brett L. Carlson, Mark A. Schroeder, Lihong He, Zeng Hu, Gautham Gampa, Matthew L. Kosel, Paul A. Decker, Gaspar J. Kitange, Anne Schmitt-Hoffmann, Felix Bachmann, Rachael A. Vaubel, Jeanette E. Eckel-Passow, Caterina Giannini, Paul Mcsheehy, Heidi A. LaneWilliam F. Elmquist, Jann N. Sarkaria

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Preclinical modeling in glioblastoma patient-derived xenograft (GBM PDX) xenografts to guide clinical development of lisavanbulin - a novel tumor checkpoint controller targeting microtubules'. Together they form a unique fingerprint.

Medicine & Life Sciences